A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19

NCT05713318 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: HH-120 nasal spray
DRUG: HH-120 nasal spray
DRUG: Placebo Comparator
DRUG: Placebo Comparator

Sponsor

Huahui Health